Expression and purification of the recombinant diphtheria fusion toxin DT 388 IL3 for phase I clinical trials

Author: Urieto J.O.   Liu T.   Black J.H.   Cohen K.A.   Hall P.D.   Willingham M.C.   Pennell L.K.   Hogge D.E.   Kreitman R.J.   Frankel A.E.  

Publisher: Elsevier

ISSN: 1046-5928

Source: Protein Expression and Purification, Vol.33, Iss.1, 2004-01, pp. : 123-133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content